-
公开(公告)号:MX2010007392A
公开(公告)日:2010-10-05
申请号:MX2010007392
申请日:2009-01-02
Applicant: ABBOTT LAB
Inventor: VASUDEVAN ANIL , KORT MICHAEL E , DIDOMENICO STANLEY JR , CHENJUN , PERNER RICHARD J
Abstract: Se describen compuestos de la fórmula (I), en donde R1, R2, R3, m, e Y se definen en la especificación y son antagonistas de TRPA1. También se describen composiciones que comprenden dichos compuestos y métodos para tratar condiciones y trastornos utilizando dichos compuestos y composiciones.
-
公开(公告)号:MX2010001486A
公开(公告)日:2010-03-01
申请号:MX2010001486
申请日:2008-08-08
Applicant: ABBOTT LAB
Inventor: VASUDEVAN ANIL , BROWN BRIAN S , GOMTSYAN ARTHUR R , KEDDY RYAN G , DAANEN JEROME F , KYM PHILIP R , KORT MICHAEL , MATULENKO MARK A
IPC: C07D401/04 , A61K31/4545
Abstract: La presente invención se refiere a compuestos de la fórmula (I), o sales farmacéuticamente aceptables, profármacos, sales de profármacos, o combinaciones de los mismos, en donde R1, R2 y R3, son definidos en la descripción. También se describen composiciones que comprenden dichos compuestos y métodos pata el tratamiento de padecimientos y enfermedades utilizando dichos compuestos y composiciones.
-
公开(公告)号:CA2697382A1
公开(公告)日:2009-03-05
申请号:CA2697382
申请日:2008-08-26
Applicant: ABBOTT GMBH & CO KG , ABBOTT LAB
Inventor: MACK HELMUT , TEUSCH NICOLE , MUELLER BERNHARD K , HORNBERGER WILFRIED , JARVIS MICHAEL F , SAUER DARYL , SWANN STEVE JR , BONAFOUX DOMINIQUE , KEDDY RYAN , HOBSON ADRIAN DONALD , VASUDEVAN ANIL
IPC: C07D213/56 , A61K31/44 , A61K31/4427 , A61P9/00 , A61P25/00 , A61P29/00 , A61P35/00 , C07D401/12 , C07D405/12 , C07D413/12 , C07D417/12
Abstract: The present invention relates to novel 4-(4-pyridyl)-benzamides of the formula (I). The compounds I possess valuable therapeutic properties and are suitable, in particular, for treating diseases that respond to modulation of Rho kinases (ROCKs). R1 and R2 are, independently of each other, hydrogen, hydroxy, cyano, C1-C8-alkyl, C1- C8-haloalkyl, C1-C8-alkoxy or C1-C8-haloalkoxy; R3, R4, R5 and R6 are, independently of each other, hydrogen, hydroxy, halogen, cyano, C1-C8-alkyl, C1-C8-haloalkyl, C1-C8-alkoxy, C1-C8-haloalkoxy, amino, C1-C8-alkylamino or di-(C1-C8-alkyl)-amino; R7 is hydrogen, C1-C8-alkyl, C1-C8-haloalkyl, aryl or aryl-C1-C8-alkyl; R8 is a group of the formula -X-W, where X is a single bond, C1-C4-alkylene or C1-C4-alkylene-O-, where the alkylene group in the three last-mentioned radicals may be linear or branched and may be partly or fully halogenated and/or may be substituted by a hydroxyl group and/or may be interrupted by an oxygen atom; and W is a cyclic radical selected from phenyl and a 5- or 6-membered saturated, partly unsaturated or aromatic heterocyclic ring which contains as ring members 1, 2 or 3 heteroatoms selected from O, S and N and optionally 1 or 2 carbonyl groups; R9 is a group of the formula -Y-Z, where Z is hydrogen, halogen, OR11, NR12R13, S(O)m-R14, phenyl which may carry 1, 2, 3 or 4 substituents R15 or a 5- or 6-membered saturated, partly unsaturated or aromatic heterocyclic ring; and Y is linear or branched C1C4-alkylene which may be partly or fully halogenated and/or may be substituted by a hydroxyl group and/or a phenyl ring; or, in case Z is phenyl or the 5- or 6-membered heterocyclic ring as defined above, Y can also be a single bond.
-
公开(公告)号:MX2008015004A
公开(公告)日:2008-12-05
申请号:MX2008015004
申请日:2007-05-24
Applicant: ABBOTT LAB
Inventor: HEXAMER LAURA , WANG LE , TONG YUNSONG , DJURIC STEVAN W , XIA ZHIREN , ZHANG HENRY Q , PENNING THOMAS D , GIRANDA VINCENT L , DIEBOLD ROBERT B , LIN NAN-HORNG , MIYASHIRO JULIE M , PRZYTULINSKA MAGDALENA , SOWIN THOMAS , SULLIVAN GERARD , TAO ZHI-FU , VASUDEVAN ANIL , WOODS KEITH W
IPC: C07C225/20 , A61K31/132 , A61K31/505 , A61P35/00 , C07D249/14 , C07D277/64 , C07D285/06 , C07D333/20
Abstract: Se describen compuestos que inhiben Plk1, composiciones que contienen los compuestos y métodos para tratar enfermedades utilizando los compuestos.
-
公开(公告)号:CA2647592A1
公开(公告)日:2007-12-06
申请号:CA2647592
申请日:2007-05-24
Applicant: ABBOTT LAB
Inventor: PRZYTULINSKA MAGDALENA , VASUDEVAN ANIL , TONG YUNSONG , DIEBOLD ROBERT B , SOWIN THOMAS , LIN NAN-HORNG , XIA ZHIREN , PENNING THOMAS D , WOODS KEITH W , WANG LE , DJURIC STEVAN W , MIYASHIRO JULIE M , ZHANG HENRY Q , TAO ZHI-FU , SULLIVAN GERARD , HEXAMER LAURA , GIRANDA VINCENT L
IPC: C07C225/20 , A61K31/132 , A61K31/505 , A61P35/00 , C07D249/14 , C07D277/64 , C07D285/06 , C07D333/20
Abstract: Compounds of formula (I) where X1, C1, and D1 are defined herein, are inhibitors of polo-like kinases. The compounds of formula (I) are useful for treatment of diseases of cellular proliferation, such as, for example, cancer.
-
公开(公告)号:BR0108088A
公开(公告)日:2004-04-06
申请号:BR0108088
申请日:2001-07-11
Applicant: ABBOTT LAB
Inventor: BENNANI YOUSSEF L , FAGHIH RAMIN , DWIGHT WESLEY J , VASUDEVAN ANIL , CONNER SCOTT E
IPC: C07D295/08 , A61K31/40 , A61K31/4025 , A61K31/4178 , A61K31/427 , A61K31/443 , A61K31/4439 , A61K31/455 , A61K31/4709 , A61K31/4725 , A61K31/496 , A61K31/506 , A61K31/5377 , A61P3/04 , A61P9/10 , A61P11/06 , A61P25/06 , A61P25/08 , A61P25/16 , A61P25/18 , A61P25/24 , A61P25/28 , A61P29/00 , A61P31/04 , A61P35/00 , A61P43/00 , C07D207/06 , C07D207/12 , C07D207/14 , C07D207/16 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/12 , C07D405/12 , C07D409/12 , C07D417/12 , C07D417/14
-
公开(公告)号:UY27750A1
公开(公告)日:2003-11-28
申请号:UY27750
申请日:2003-04-04
Applicant: ABBOTT LAB
Inventor: DINGES JURGEN , HAVIV FORTUNA , VASUDEVAN ANIL , BRADLEY MICHAEL F , SAUER DARYL R , PARK DAVID C , HENKIN JACK , KOLACZKOWSKI LAWRENCE
IPC: A61P9/14 , A61K31/44 , C07D211/00 , C07D213/00 , C07D213/16
Abstract: Compuestos que tienen la fórmula son inhibidores de la angiogénesis. También se describen composiciones que contienen los compuestos, métodos para su preparación y métodos de tratamiento en los que se usan los compuestos.
-
公开(公告)号:CA2481240A1
公开(公告)日:2003-10-23
申请号:CA2481240
申请日:2003-04-03
Applicant: ABBOTT LAB
Inventor: HAVIV FORTUNA , KOLACZKOWSKI LAWRENCE , DINGES JUERGEN , SAUER DARYL R , PARK DAVID C , HENKIN JACK , BRADLEY MICHAEL F , VASUDEVAN ANIL
IPC: C07D241/24 , A61K31/4439 , A61K31/444 , A61K31/4545 , A61K31/455 , A61K31/4747 , A61K31/496 , A61K31/497 , A61K31/506 , A61K31/5355 , A61K31/541 , A61K31/551 , A61P1/00 , A61P3/10 , A61P5/00 , A61P9/00 , A61P15/00 , A61P17/00 , A61P27/02 , A61P35/00 , C07D213/81 , C07D213/82 , C07D239/28 , C07D401/04 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/06 , C07D405/04 , C07D405/12 , C07D405/14 , C07D409/04 , C07D409/14 , C07D491/10 , C07D491/113
Abstract: Compounds having the formula (I) are angiogenesis inhibitors. Also disclosed are compositions containing the compounds, methods of making the compounds, and methods of treatment using the compounds. A is selected from the group consisting of pyridine, pyridine N-oxide, pyridazine, pyrimidine. pyrazine, and triazine; R1 and R2, together with the nitrogen atom to which they are attached, form a five - to eight - membered ring containing an additional ze ro to two heteroatoms selected from the group consisting of nitrogen, oxygen, a nd sulfur; wherein the ring can be optionally substituted with one, two, or thr ee substituents independently selected from the group consisting of alkoxyalkyl , alkoxycarbonyl, alkyl, unsubstituted alkylcarbonyl, amino, aminocarbonyl, aryl, arylalkoxycarbonyl, wylalkyl, carboxy, formyl, haloalkyl, heterocycle, (heterocycle)alkyl, hydroxy, hydroxyalkoxyalkyl, hydroxyalkyl, and spiroheterocycle; R3 at each occurance is independently selected from the group consisting 'of alkenyl, alkoxy, alkoxyalkyl, alkoxycarbonyl, alkyl, unsubstituted alkylcarbonyl, alkylsulfanyl, amino, aminocarbonyl, aryl, arylalkyl, aryloxy, cyano, cyanoalkyl, cyanoalkyl, (cycloalkyl)alkyl, halo, haloalkyl, heterocycle, hydroxy, hydroxyalkyl, and nitro; X is selected from the group consisting of O, S, and CH2; and m is 0-4.
-
公开(公告)号:AU4340202A
公开(公告)日:2002-06-18
申请号:AU4340202
申请日:2001-10-26
Applicant: ABBOTT LAB
Inventor: CURTIN MICHAEL L , DAI YUJIA , DAVIDSEN STEVEN K , FREY ROBIN R , GUO YAN , HEYMAN HOWARD R , HOLMS JAMES H , JI ZHIQIN , MICHAELIDES MICHAEL R , VASUDEVAN ANIL , WADA CAROL K
IPC: C07C45/29 , C07C45/30 , C07C45/45 , C07C45/51 , C07C45/67 , C07C47/277 , C07C49/255 , C07C59/90 , C07C69/716 , C07C235/14 , C07C235/16 , C07C235/20 , C07C235/74 , C07C235/80 , C07C243/38 , C07C255/54 , C07C255/60 , C07C311/19 , C07C317/32 , C07C317/44 , C07C323/41 , C07C323/60 , C07D209/08 , C07D209/42 , C07D213/30 , C07D213/40 , C07D213/75 , C07D215/38 , C07D231/40 , C07D235/06 , C07D257/04 , C07D263/14 , C07D263/32 , C07D263/58 , C07D271/10 , C07D277/46 , C07D277/56 , C07D277/74 , C07D277/82 , C07D285/08 , C07D295/112 , C07D307/68 , C07D307/85 , C07D317/58 , C07D317/66 , C07D317/68 , C07D413/04 , C07D413/12 , C07D417/04 , C07D491/10
Abstract: Substituted trifluoromethyl ketones, ketooxazoles, ketoamides, ketoesters, and diketones having the formula or therapeutically acceptable salts thereof, are histone deacetylase (HDAC) inhibitors. Preparation of the compounds, compositions containing the compounds, and treatment of diseases using the compounds are disclosed.
-
公开(公告)号:BRPI0811065A2
公开(公告)日:2014-12-02
申请号:BRPI0811065
申请日:2008-06-04
Applicant: ABBOTT LAB , ABBOTT GMBH & CO KG
Inventor: AKRITOPOULOU-ZANZE IRINI , WAKEFIELD BRIAN D , MACK HELMUT , TURNER SEAN C , GASIECKI ALAN F , GRACIAS VIJAVA J , SARRIS KATHY , KALVIN DOUGLAS M , MICHMERHUIZEN MELISSA J , SHUAI QI , PATEL JYOTI R , BAKKER MARGARETHA , TEUSCH NICOLE , JOHNSON ERIC F , KOVAR PETER J , DJURIC STEVAN W , LONG ANDREW J , VASUDEVAN ANIL , HOBSON ADRIAN , MOORE NIGEL ST JOHN , WANG LU , GEORGE DAWN , LI BIQIN , FRANK KRISTINE
IPC: C07D403/04 , C07D413/04 , C07D417/04
-
-
-
-
-
-
-
-
-